Results 11 to 20 of about 84,732 (212)

MORPHOLOGICAL ANALYSIS OF HEPATITIS B VIRUS WITH ESCAPE MUTATIONS IN S-gene G145R AND S143L

open access: yesВопросы вирусологии, 2017
Background. In terms of serological properties and immunization, the wild type of HBsAg HBV and its G145R mutant behave as different antigens. This testifies to serious structural changes, which presumably could have a significant impact on the ...
M. V. Konopleva   +9 more
doaj   +1 more source

IL-10 Promoter Polymorphism Distribution among HBsAg-Reactive and HBsAg-Nonreactive Blood Donors

open access: yesMajalah Kedokteran Bandung, 2020
Hepatitis B surface antigen (HBsAg) serves as a serological marker for Hepatitis B virus (HBV) infection. People with HBV asymptomatic infection might readily donate blood due to the lack of clinical manifestations.
Rahmat Azhari Kemal   +5 more
doaj   +1 more source

Kan vericilerde HBsAg, anti-HCV, anti-HIV ve Sifilis seroprevalansı

open access: yesSakarya Tıp Dergisi, 2011
Bu çalışmada Afyon Kocatepe Üniversitesi Tıp Fakültesi Kan Merkezi'ne başvuran donörlerde HBsAg, anti-HCV, anti-HIV 1/2 ve RPR seroprevalansının tespiti ve oranların yıllara ve cinsiyete göre dağılımının belirlenmesi amaçlanmıştır.
Mustafa Altındiş   +2 more
doaj   +1 more source

Distribution of ABO, Rhesus Blood Groups, Transfusion Transmitted Diseases and Adverse Donor Reactions in a Blood Bank of a Tertiary Care Hospital: A Five Year Study [PDF]

open access: yesNational Journal of Laboratory Medicine, 2016
Introduction: Study of the distribution of A, B, O blood group systems is essential for genetic studies, medico – legal issues and importantly for efficient delivery of blood bank services. Also important is the immunologic safety of the donated blood
Lekha Mandodar   +2 more
doaj   +1 more source

The prevalence of viral hepatitis D in the world

open access: yesЭпидемиология и вакцинопрофилактика, 2022
Relevance According to many researchers, hepatitis D worsens the prognosis of hepatitis B in 80–90% of cases, accelerating fibrosis and leading to liver cirrhosis or hepatocellular carcinoma. Aims. To present a review of data on prevalence of hepatitis D
V. G. Akimkin   +5 more
doaj   +1 more source

An expert consensus for the management of chronic hepatitis B in Asian Americans. [PDF]

open access: yes, 2018
BACKGROUND: Hepatitis B virus (HBV) infection is common with major clinical consequences. In Asian Americans, the HBsAg carrier rate ranges from 2% to 16% which approximates the rates from their countries of origin.
Abbas   +173 more
core   +2 more sources

Using the quantitative determination of HBsAg to predict the course of chronic hepatitis B in women during pregnancy and after childbirth

open access: yesЖурнал инфектологии, 2014
This study is based on the investigation of 31 HB V-infected women, which have observed at Botkin Infectious Hospital in 2012. Considerable variations of viral load in the course of pregnancy have been observed in the HB V cohort.
M. A. Belopolskaya   +3 more
doaj   +1 more source

Prevalence of Hepatitis B and Hepatitis C in patients undergoing hemodialysis at a teaching hospital in Uttarakhand

open access: yesJournal of Family Medicine and Primary Care, 2022
Introduction: Hemodialysis (HD) requires blood exposure to infectious materials through the extracorporeal circulation for a prolonged period, and exposure to risk factors for nosocomial infections is always there.
Dimple Raina, Neha Rawat, Ajay K Pandita
doaj   +1 more source

HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets [PDF]

open access: yes, 2018
Chronic HBV + HDV infection is associated with greater risk of liver fibrosis, earlier hepatic decompensation, and liver cirrhosis hepatocellular carcinoma compared to HBV mono-infection.
Andreoni, Massimo   +34 more
core   +2 more sources

Reactivation of hepatitis B virus with immune-escape mutations after ocrelizumab treatment for multiple sclerosis [PDF]

open access: yes, 2019
Ocrelizumab is an anti-CD20 monoclonal antibody for the treatment of multiple sclerosis (MS) that is closely related to rituximab. We describe a case of hepatitis B virus (HBV) reactivation in an MS patient with resolved HBV infection receiving ...
Altieri, Marta   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy